Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed herein are carbonyl compounds of Formula I as described herein.
Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone disorders, polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, cardiovascular conditions, and disorders in which angiogenesis play a role in pathogenesis, using the compounds of the invention. In addition, methods of modulating the activity of histone deacetylase (HDAC) are also disclosed.
31 Citations
43 Claims
Specification